AIDS Treatment News logo      

April 13, 2010

HIV Drugs Also Target Prostate Cancer and Chronic Fatigue Virus

"Four antiretrovirals (ARVs), notably Merck’s integrase inhibitor Isentress (raltegravir), can inhibit a virus linked to prostate cancer and chronic fatigue syndrome, according to a press release from Emory University in Atlanta highlighting a paper published online earlier this month by the journal PLoS ONE.

"Discovered in 2006, xenotropic murine leukemia virus (XMRV) has been detected in some prostate cancer patients’ tumor biopsies. However, its precise role in driving prostate cancer is unclear. In addition, a research team at the Whittemore Peterson Institute in Nevada has suggested that XMRV is the causative agent of chronic fatigue syndrome in a majority of patients. However, other laboratories have yet to confirm these results."

Read more:, April 12, 2010.